-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
February 01, 2013 - 1
Comparative Effectiveness Review
Number 104
Intravascular Diagnostic Procedures and
Imaging Techniques Versus Angiography
Alone in Coronary Artery Stenting:
Comparative Effectiveness Review
Executive Summary
Background
Coronary artery disease (CAD) involves
narrowing (stenosis) of one or more of
the ep…
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - • A diagnosis of end stage renal disease (ESRD) or receiving dialysis therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
April 18, 2013 - We clarified that during the topic refinement
stage, we solicited input from Key Informants
representing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/field-triage-glascow-disposition-170415.pdf
January 12, 2017 - Peer Reviewer #1 Introduction appropriately sets the stage for the review Thank you.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/aggression_research-protocol.pdf
October 05, 2015 - The use of restrictive
interventions, such as restraints, at this early stage may only further escalate
-
digital.ahrq.gov/sites/default/files/docs/page/Research%20Agenda%20for%20Healthcare%20Systems%20Engineering.pdf
February 13, 2007 - At every stage, from delicate surgery to home and rural care,
healthcare is a team effort.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
March 01, 2022 - There is insufficient evidence about CT
accuracy to stage acute diverticulitis.
-
effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
April 01, 2016 - Appendix B provides a complete
list of articles excluded at the full-text screening
stage, with reasons
-
www.ahrq.gov/sites/default/files/2024-11/gershon-report.pdf
January 01, 2024 - Outline of Study Management Plan
Phase 1: Formative Stage and Safety
Survey Tool Development
(months
-
www.ahrq.gov/sites/default/files/2024-04/koss-report.pdf
January 01, 2024 - Phase 3: Incident Report Data Collection and Ontology Development
During the final stage of the study
-
www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Sampling-Weighting-Synthetization-Methodologies.pdf
December 01, 2023 - For Medicare, the coverage qualification reasons
were “End-stage renal disease (ESRD),” “Disability
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening-1996
January 01, 1996 - with CD4 < 200/ micro-L, 85 , 86 and half of all HIV-infected persons are still asymptomatic at this stage
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
February 22, 2012 - references not included within our citation database will be
retrieved and screened for eligibility at the stage
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
April 26, 2022 - CRC mortality for aspirin users over this 5-year period, apparently due to a shift in greater late-stage
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
June 01, 2013 - During the topic refinement stage, we solicited input
from Key Informants representing medical professional
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables1.xls
May 29, 2025 - Ingredient, Age, Gender, and Race
Note: A dash signifies a small cell count (less than 11); ESRD = end stage
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
January 01, 2020 - Post-diagnosis weight gain
and breast cancer recurrence in women with early stage breast
cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-2.xlsx
January 01, 2017 - FHR: 0.18% vs. 0.39%
RR 0.46 (95% CI 0.048 to 4.37)
(1 additional CD for FHR abnormality during 1st stage
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/reducing-adverse-drug-1.pdf
March 01, 2020 - extensive discontinuation of drugs, dose reductions, or decisions
to revise medications at a later stage
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/SJbAXUAQTv2GWemMuBab6W
April 08, 2025 - through
other sources
(eg, reference lists, experts)
3430 Citations excluded at title and abstract stage